Clinical Trials List
2007-08-01 - 2011-07-31
Phase II/III
Terminated10
ICD-10C78.5
Secondary malignant neoplasm of large intestine and rectum
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.5
Secondary malignant neoplasm of large intestine and rectum
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Been Ren Lin Division of Hematology & Oncology
- 蕭仲凱 Division of Hematology & Oncology
- 張金堅 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林建良 Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- 馮盈勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 靳志堅 Division of Colorectal Surgery
- 郭益宏 Division of Colorectal Surgery
- 葉重宏 Division of Colorectal Surgery
- 黃文詩 Division of Colorectal Surgery
- Kuan-Der Lee Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張正雄 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林增熙 Division of Colorectal Surgery
- FAN -FENG CHIANG Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王緯書 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃麟傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳秉聰 Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王心泰 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
720 participants
